Expanding the framework of assessing adherence and medication-taking behavior

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 27, Issue 2, 2013, Pages 114-124

  Alsalman, Abdulkhaliq J ^a   Smith, Wally R ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Compliance; Health behavior; Medication adherence; Momentary assessment; Nomenclature; Pharmacotherapy outcomes; Terminology

Indexed keywords

IBUPROFEN; METHYLPREDNISOLONE; MONTELUKAST; SALBUTAMOL;

ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CONCEPTUAL FRAMEWORK; DIGESTIVE SYSTEM ULCER; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; MEDICAL RESEARCH; MEDICATION COMPLIANCE; METERED DOSE INHALER; PATIENT ATTITUDE; PATIENT COMPLIANCE; SELF CARE; SELF MONITORING; TACHYCARDIA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

DRUG ADMINISTRATION SCHEDULE; HUMANS; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS; TERMINOLOGY AS TOPIC;

EID: 84879396832     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2013.765532     Document Type: Article

References (70)

1. National Council on Patient Information and Education. enhancing prescription medication adherence: a national action plan. Available at: http://www.talkaboutrx.org/documents/enhancingprescriptionmedicineadherence.pdf. Accessed September 15, 2012.
2. Stewart RB, Cluff LE. A review of medication errors and compliance in ambulant patients. Clin Pharmacol Ther. 1972;13:463-468.
3. Rand CS, Weeks K. Measuring adherence with medication regimens in clinical care and research. In Shumaker SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer; 1998:114-132.
4. Berg JS, Dischler J,Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27:S1-S24.
5. Schaub AF, Steiner A, VetterW. Compliance to treatment. Clin Exp Hypertens. 1993;15:1121-1130.
6. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereik SM, DoswellWM. Adherence in chronic disease. Annu Rev. Nurs Res 2000;18:49-90.
7. Watters RE. Regulating: the social control process registered nurses use to teach psychiatric patients about their medications. Issues Ment Health Nurs. 2000;21:411-431.
8. Saxena S. Pharmacotherapy of compulsive hoarding [review]. J Clin Psychol. 2011;67:477-484.
9. Chue P, Prinzo RS, BinderCE. Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets. Hum Psychopharmacol. 2007;22:307-314.
10. Morin AK. Possible intranasal quetiapine misuse. Am J Health Syst Pharm. 2007;64:723-725.
11. Sokol MC, McGuigan KA, Verbrugge, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
12. National Community Pharmacists Association. Take as directed: a prescription not followed. Research conducted by The Polling Company.TM Alexandria, VA: December 2006.
13. Shaner A, Eckman T, Roberts LJ, Fuller T. Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatr Serv. 2003;54:1287-1289.
14. Phillips CO, Wright S, Kern DE, et al. Comprehensive discharge planning with post discharge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004;291:1358-1367.
15. DiMatteoMR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
16. Shrank WH, Porter ME, Jain SH, Choudhry NK. A Blueprint for Pharmacy BenefitManagers to Increase Value. Am J Manag Care. 2009;15:87-93.
17. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review [review]. J Clin Pharm Ther. 2001;26:331-342.
18. LaFleur J, Nelson RE, Sauer BC, Nebeker JR. Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart. 2011;97:1862-1869.
19. Horne R. Compliance, adherence, and concordance: implications for asthma treatment [review]. Chest. 2006;130(1 Suppl):65S-72S.
20. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions [review]. Value Health. 2008;11:44-47.
21. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults [review]. Med Clin North Am. 2009;93:753-769.
22. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity [review]. Am J Geriatr Pharmacother. 2011;9:11-23.
23. Garć a-Ribera C, Bulbena A. Determinants of medicinetaking in psychiatric patients [review]. Curr Clin Pharmacol. 2011;6:100-107.
24. World Health Organization. Adherence to Long-Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
25. Osterberg L, Blaschke T. Adherence to medication [review]. N Engl J Med. 2005;353:487-497.
26. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice [review]. Clin Ther. 1999;21:1074-1090; discussion 1073.
27. Spilker B. Methods of assessing and improving compliance in clinical trials. In Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991:37-56.
28. Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review [review]. Addiction. 2008;103:1242-1257.
29. DiMatteoMR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
30. Hess LM, Saboda K, Malone DC, Salasche S, Warneke J, Alberts DS. Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2579-2583.
31. Hill MN, Miller NH, Degeest S, et al. Adherence and persistence with taking medication to control high blood pressure. J Am Soc Hypertens. 2011;5:56-63.
32. Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16:1120-1128.
33. GilbergK, LaouriM,Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm. 2003;9:232-237.
34. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99:837-841.
35. Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook D. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage. 2000;20:293-307.
36. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326:501-506.
37. Dekker FW, Dieleman FE, Kaptein AA, Mulder JD. Compliance with pulmonary medication in general practice. Eur Respir J. 1993;6:886-890.
38. Ryan GW,WagnerGJ. Pill taking 'routinization': a critical factor to understanding episodic medication adherence. AIDS Care. 2003;15:795-806.
39. Rudd P, Byyny RL, Zachary V, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988;1(3 Pt 1):309-312.
40. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther. 1989;46:163-168.
41. Cramer JA, Scheyer RD,Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-1510.
42. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47:826-834.
43. Thompson C, Pledger L. Doctor-patient communication: is patient knowledge of medical terminology improving? Health Commun. 1993;5:89-97.
44. Ben-Arye E, Bar-Sela G, Frenkel M, Kuten A, Hermoni D. Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Support Care Cancer. 2006;14:147-152.
45. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.
46. Nieuwkerk PT, de Boer-van der Kolk IM, Prins JM, Locadia M, Sprangers MA. Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antivir Ther. 2010;15:913-916.
47. King MF, Bruner GC. Social desirability bias: a neglected aspect of validity testing. Psychol Marketing. 2000;17:79-103.
48. Kravitz RL, Bell RA, Franz CE, et al. Characterizing patient requests and physician responses in office practice. Health Serv Res. 2002;37:217-238.
49. van deMortel TF. Faking it: social desirability bias in self-report research. Aust J Adv Nurs. 2008;25:40-48.
50. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000 10;14:357-366.
51. Montaner JS, Reiss P, Cooper D, et al. A randomized, doubleblind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA. 1998 25;279:930-937.
52. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30. Erratum in: Ann Intern Med 2002;136:253.
53. Greaves CJ, Hyland ME, Halpin DM, Blake S, Seamark D. Patterns of corticosteroid medication use: non-adherence can be effective in milder asthma. Prim Care Respir J. 2005;14:99-105.
54. Carlquist JF, Anderson JL. Pharmacogenetic mechanisms underlying unanticipated drug responses [review]. Discov Med. 2011;11:469-478.
55. National Health Institute (NIH). Request for Information (RFI): Priorities for the NIH Adherence Research Network. Available at: http://grants.nih.gov/grants/guide/noticefiles/NOT-OD-10-078.html. Accessed September 15, 2012.
56. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277. Erratum in: JAMA 1989 15;262:1472.
57. Stone AA, Shiffman S, Schwartz JE, Broderick JE,HuffordMR. Patient compliance with paper and electronic diaries. Control Clin Trials. 2003;24:182-199.
58. Oldenmenger WH, Echteld MA, de Wit R, et al. Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary. J Pain Symptom Manage. 2007;34:639-647.
59. McCall C, Maynes B, Zou CC, Zhang NJ. RMAIS: RFIDbased medication Adherence Intelligence System. Proceedings of 32nd Annual International Conference of the IEEE EMBS. Buenos Aires, Argentina, August 31-September 4, 2010:3768-3771.
60. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records:methods, validity, and applications [review]. J Clin Epidemiol. 1997;50:105-116.
61. Hess LM, Raebel MA, Conner DA, Malone DC.Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288.
62. Rudd P, Byyny RL, Zachary V, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988;1:309-312.
63. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications [review]. Lancet. 1996;348:383-386. Erratum in: Lancet 1997;349:1180.
64. Polonsky WH, Earles J, Smith S, et al. Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care. 2003;26:3048-3053.
65. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154-2160.
66. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment [review]. Annu Rev Clin Psychol. 2008;4:1-32.
67. Shiffman S. Ecological momentary assessment (EMA) in studies of substance use [review]. Psychol Assess. 2009;21:486-497.
68. Substance Abuse and Mental Health Services Administration. Misuse of Prescription Drugs: Data From the 2002, 2003, and 2004 National Surveys on Drug Use and Health. Rockville, MD: Office of Applied Studies; 2006. Department of Health and Human Services Publication No. (SMA) 06-4192.
69. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. National Survey on Drug Use and Health Series H-41, Department of Health and Human Services Publication No. (SMA) 11-4658.
70. Berg J, Dunbar-Jacob J, Rohay JM. Compliance with inhaled medications: the relationship between diary and electronicmonitor. Ann Behav Med. 1998;20:36-38.